1d
Zacks Investment Research on MSNIs Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...
The Senate health committee announced Thursday morning that it was canceling a planned hearing on Weldon’s nomination because ...
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...
3d
Zacks Investment Research on MSNIs it Worth Retaining QIAGEN Stock in Your Portfolio Now?QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...
The U.K. Christian right is increasingly drawing on a U.S.-forged playbook. It is also drawing on U.S. money. But the U.K.
A National Institutes of Health study aims to find out whether ultraprocessed foods lead people to eat more. And, if so, why? Teasing out the answers could shed light on ...
Chaffee County sent nine competitive Destination Imagination teams to compete at the regionals March 8-9 in Pueblo – and all ...
Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.
Diller Scofidio + Renfro is designing a new purpose-built home for the Frederick S. Pardee School for Global Studies at ...
A growing roster of towers is going up for sale for the first time since the COVID-19 pandemic shook up demand for office ...
The Boston Society for Architecture's annual design honors have been awarded, and the winners range from a Weston farmstand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results